Table 6.
Baseline univariate and multivariate predictors of mortality in patients treated with biologic drugs.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| HR (95% CI) | p value | HR (95% CI) | p value | |
| Age | 1.04 (0.99-1.08) | 0.07 | 1.043 (1-1.09) | 0.048 |
| Sex (F) | 1.039 (0.306-3.527) | 0.95 | ||
| HBP | 1.28 (0.54-3.04) | 0.574 | . | |
| CAD | 4.89 (1.89-12.64) | 0.001 | 1.95 (0.61-6.3) | 0.27 |
| PaO2/FiO2 ratio (mmHg) | 0.98 (0.96-99) | 0.01 | 0.98 (0.965-0.997) | 0.045 |
| LAD | 1.004 (1.00-1.01) | 0.002 | 1.004 (1.001-1.007) | 0.01 |
| CRP | 1.001 (0.996-1.007) | 0.61 | ||
| Ferritin | 1 (1-1) | 0.65 | ||
| IL-6 | 1 (0.99-1.01) | 0.12 | ||
Results are reported as hazard ratio and 95% confidence interval; statistically significant p value < 0.05. HBP, high blood pressure; CAD, coronary artery disease; LAD, lactate dehydrogenase; CRP, C-reactive protein; IL-6, interleukin-6; HR, hazard ratio; CI, confidence interval.
Bold values indicate that the p values are statistically significant.